Class II Phosphoinositide 3-Kinases as Novel Drug Targets

QR Code

Class II Phosphoinositide 3-Kinases as Novel Drug Targets

Â© 2016 American Chemical Society. The phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases central to regulating a wide range of important intracellular processes. Despite the vast knowledge around class I PI3Ks, the class II PI3Ks have been neglected, seemingly only due to the chronolo...

Full description

Bibliographic Details
Main Authors:	Falasca, Marco, Hamilton, J., Selvadurai, M., Sundaram, K., Adamska, A., Thompson, P.
Format:	Journal Article
Published:	American Chemical Society 2017
Online Access:	http://hdl.handle.net/20.500.11937/63469

Similar Items

Regulation and cellular functions of class II phosphoinositide 3-kinases
by: Falasca, Marco, et al.
Published: (2012)

New insight into the intracellular roles of class II phosphoinositide 3-kinases
by: Maffucci, T., et al.
Published: (2014)

Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)

Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
by: Tibolla, G., et al.
Published: (2013)

3-phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
by: Fyffe, C., et al.
Published: (2013)

Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
by: Edling, C., et al.
Published: (2010)

Novel roles for class II Phosphoinositide 3-Kinase C2ß in signalling pathways involved in prostate cancer cell invasion.
by: Mavrommati, I., et al.
Published: (2016)

Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms
by: Fyffe, C., et al.
Published: (2013)

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer - from molecular signalling to clinical trials
by: Falasca, Marco, et al.
Published: (2011)

THE CLASS II PHOSPHOINOSITIDE 3-KINASE ISOFORM beta REGULATES PLATELET FUNCTION AND ARTERIAL THROMBOSIS IN MICE
by: Tibolla, G., et al.
Published: (2011)

Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic ß cells
by: Dominguez, V., et al.
Published: (2011)

Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
by: Edling, C., et al.
Published: (2014)

Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression.
by: Chikh, A., et al.
Published: (2016)

Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)

Analysis, regulation, and roles of endosomal phosphoinositides
by: Maffucci, T., et al.
Published: (2014)

Phosphoinositides signalling in cancer: Focus on PI3K and PLC
by: Raimondi, C., et al.
Published: (2012)

A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation
by: Maffucci, T., et al.
Published: (2009)

Elucidation of the WNT & AKT/Phosphoinositide-3-Kinase Pathways in Colorectal Carcinoma
by: Khor, Tin Oo
Published: (2004)

Kinase targets in CNS drug discovery
by: Gunosewoyo, Hendra, et al.
Published: (2017)

PITPs as targets for selectively interfering with phosphoinositide signaling in cells
by: Nile, A., et al.
Published: (2014)

Functional association of phosphoinositide-3-kinase with platelet glycoprotein Iba, the major ligand-binding subunit of the glycoprotein Ib-IX-V complex
by: Mu, F., et al.
Published: (2010)

Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
by: Castresana, Javier S., et al.
Published: (2017)

ABC transporters and G protein-coupled receptors: perspectives for novel anti-cancer drugs
by: Adamska, Aleksandra
Published: (2019)

ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
by: Adamska, A., et al.
Published: (2018)

Akt/protein kinase B in skeletal muscle physiology and pathology
by: Wu, M., et al.
Published: (2011)

Targeting PDK1 in cancer
by: Raimondi, C., et al.
Published: (2011)

Pancreatic ductal adenocarcinoma: Current and evolving therapies
by: Adamska, A., et al.
Published: (2017)

ABC transporters as cancer drivers: Potential functions in cancer development
by: Domenichini, Alice, et al.
Published: (2019)

From microbial gene essentiality to novel antimicrobial drug targets
by: Mobegi, Fredrick, et al.
Published: (2014)

Cyclin dependent Kinases as potential therapeutic targets for atherosclerosis
by: Rostam, Muhamad Ashraf, et al.
Published: (2015)

Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
by: Alsayed, S., et al.
Published: (2018)

Targeting PDK1 for Chemosensitization of Cancer Cells.
by: Emmanouilidi, A., et al.
Published: (2017)

Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts
by: Falasca, Marco, et al.
Published: (2014)

Self-assembling tyrosine kinase inhibitors for localised targeted delivery
by: Al-Ameedee, Mohammed
Published: (2017)

Development of a novel azaspirane that targets the Janus Kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo
by: Mohan, C., et al.
Published: (2014)

Human apurinic/apyrimidinic endonuclease is a novel drug target in cancer
by: Abbotts, Rachel, et al.
Published: (2011)

Targeting platelets for the treatment of cancer
by: Elaskalani, Omar, et al.
Published: (2017)

The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets
by: Canobbio, I., et al.
Published: (2015)

The role of the focal adhesion kinase Pyk2 in platelet activation
by: Cipolla, L., et al.
Published: (2011)

The role of the focal adhesion kinase PYK2 in platelet activation
by: Canobbio, I., et al.
Published: (2011)